Literature DB >> 7096301

Purification and properties of soluble NADH-cytochrome b5 reductase of rabbit erythrocytes.

T Yubisui, M Takeshita.   

Abstract

Soluble NADH-cytochrome b5 reductase was purified from rabbit erythrocytes to homogeneity by simple procedures developed in this study including fractionation with ammonium sulfate, gel filtration on a Sephadex G-75 column, and affinity chromatography on a 5'-AMP-Sepharose 4B column. The enzyme was purified about 12,000-fold from hemolysate in terms of NADH-cytochrome b5 reductase activity with a high yield of 40%. The purified enzyme has absorption maxima at 273, 390, and 462 nm, and shoulders at 370, 435, and 488 nm. The ratio of the absorbance at 273 nm to that at 462 nm of the purified enzyme was 5.6-5.8. The prosthetic group of the enzyme was found to be FAD, and the flavin content in the enzyme was 1 mol/mol of the enzyme. The molecular weight of the purified enzyme was estimated to be 33,000 and 32,000 by gel filtration on a Sephadex G-75 column, and by electrophoresis on polyacrylamide gel in the presence of sodium dodecyl sulfate, respectively. The NADH-cytochrome b5 reductase activity decreased strikingly as the buffer or salt concentration in the assay mixture was increased, and the optimal pH for the reduction of cytochrome b5 with NADH was determined to be 6.6 in Tris-maleate buffer of constant ionic strength. The maximum velocity of NADH-cytochrome b5 reductase activity of the purified enzyme was very high, 1,280 mumol/min/mg of protein in 10 mM phosphate buffer (pH 6.6). The Michaelis constants for NADH and cytochrome b5 were determined to be 2.5 and 4 microM, respectively. The reduction of cytochrome b5 with NADH by the enzyme was suggested to follow the ordered-type reaction mechanism based on the modes of product inhibition. From these results, and also from the estimated enzyme content in the erythrocytes (16-20 mg protein per liter of packed erythrocytes), the possible contribution of the enzyme to functions other than methemoglobin reduction in rabbit erythrocytes is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7096301     DOI: 10.1093/oxfordjournals.jbchem.a133838

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

1.  Molecular cloning of cDNAs of human liver and placenta NADH-cytochrome b5 reductase.

Authors:  T Yubisui; Y Naitoh; S Zenno; M Tamura; M Takeshita; Y Sakaki
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

2.  The inhibitory effect of halides and carboxylates on hepatic NADH: cytochrome b5 oxidoreductase.

Authors:  M Tamura; T Yubisui; M Takeshita
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

3.  Molar absorptivity and A1%1cm values for proteins at selected wavelengths of the visible and ultraviolet regions. XXIV.

Authors:  D M Kirschenbaum
Journal:  Appl Biochem Biotechnol       Date:  1985-08       Impact factor: 2.926

4.  Dihydroceramide:sphinganine C-4-hydroxylation requires Des2 hydroxylase and the membrane form of cytochrome b5.

Authors:  Ayako Enomoto; Fumio Omae; Masao Miyazaki; Yasunori Kozutsumi; Toshitsugu Yubisui; Akemi Suzuki
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

5.  Cytochrome b₅ reductase-cytochrome b₅ as an active P450 redox enzyme system in Phanerochaete chrysosporium: atypical properties and in vivo evidence of electron transfer capability to CYP63A2.

Authors:  Khajamohiddin Syed; Chandramohan Kattamuri; Thomas B Thompson; Jagjit S Yadav
Journal:  Arch Biochem Biophys       Date:  2011-03-02       Impact factor: 4.013

6.  Modulation of sensitivity to mitomycin C and a dithiol analogue by tempol in non-small-cell lung cancer cell lines under hypoxia.

Authors:  T Bando; K Kasahara; K Shibata; Y Numata; U Heki; H Shirasaki; K Iwasa; M Fujimura; T Matsuda
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

7.  Familial Congenital Methemoglobinemia in Pomeranian Dogs Caused by a Missense Variant in the NADH-Cytochrome B5 Reductase Gene.

Authors:  H Shino; Y Otsuka-Yamasaki; T Sato; K Ooi; O Inanami; R Sato; M Yamasaki
Journal:  J Vet Intern Med       Date:  2018-01-22       Impact factor: 3.333

8.  Establishment and characterization of non-small cell lung cancer cell lines resistant to mitomycin C under aerobic conditions.

Authors:  K Shibata; K Kasahara; T Bando; Y Nakatsumi; M Fujimura; T Tsuruo; T Matsuda
Journal:  Jpn J Cancer Res       Date:  1995-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.